Literature DB >> 28966792

Cationic Acrylate Oligomers Comprising Amino Acid Mimic Moieties Demonstrate Improved Antibacterial Killing Efficiency.

James L Grace1,2, Alysha G Elliott3, Johnny X Huang3, Elena K Schneider2, Nghia P Truong1, Matthew A Cooper3, Jian Li2, Thomas P Davis1,4, John F Quinn1, Tony Velkov2, Michael R Whittaker1.   

Abstract

Cu(0)-mediated polymerization was employed to synthesize a library of structurally varied cationic polymers and their application as antibacterial peptide mimics was assessed. Eight platform polymers were first synthesized with low degrees of polymerization (DP) using (2-Boc-amino)ethyl acrylate as the monomer and either ethyl α-bromoisobutyrate or dodecyl 2-bromoisobutyrate as the initiator (thus providing hydrocarbon chain termini of C2 or C12, respectively). A two-step modification strategy was then employed to generate the final sixteen-member polymer library. Specifically, an initial deprotection was employed to reveal the primary amine cationic polymers, followed by guanylation. The biocidal activity of these cationic polymers was assessed against various strains of Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, and Streptococcus pneumoniae. Polymers having a short segment of guanidine units and a C12 hydrophobic terminus were shown to provide the broadest antimicrobial activity against the panel of isolates studied, with MIC values approaching those for Gram-positive targeting antibacterial peptides: daptomycin and vancomycin. The C12-terminated guanidine functional polymers were assayed against human red blood cells, and a concomitant increase in haemolysis was observed with decreasing DP. Cytotoxicity was tested against HEK293 and HepG2 cells, with the lowest DP C12-terminated polymer exhibiting minimal toxicity over the concentrations examined, except at the highest concentration. Membrane disruption was identified as the most probable mechanism of bacteria cell killing, as elucidated by membrane permeability testing against E. coli.

Entities:  

Year:  2016        PMID: 28966792      PMCID: PMC5615857          DOI: 10.1039/C6TB02787C

Source DB:  PubMed          Journal:  J Mater Chem B        ISSN: 2050-750X            Impact factor:   6.331


  32 in total

1.  Interactions of bacterial cationic peptide antibiotics with outer and cytoplasmic membranes of Pseudomonas aeruginosa.

Authors:  L Zhang; P Dhillon; H Yan; S Farmer; R E Hancock
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

Review 2.  Designing antimicrobial peptides: form follows function.

Authors:  Christopher D Fjell; Jan A Hiss; Robert E W Hancock; Gisbert Schneider
Journal:  Nat Rev Drug Discov       Date:  2011-12-16       Impact factor: 84.694

Review 3.  AApeptides as a new class of antimicrobial agents.

Authors:  Youhong Niu; Haifan Wu; Yaqiong Li; Yaogang Hu; Shruti Padhee; Qi Li; Chuanhai Cao; Jianfeng Cai
Journal:  Org Biomol Chem       Date:  2013-05-31       Impact factor: 3.876

4.  "Doubly selective" antimicrobial polymers: how do they differentiate between bacteria?

Authors:  Karen Lienkamp; Kushi-Nidhi Kumar; Abhigyan Som; Klaus Nüsslein; Gregory N Tew
Journal:  Chemistry       Date:  2009-11-02       Impact factor: 5.236

Review 5.  Strategies employed in the design and optimization of synthetic antimicrobial peptide amphiphiles with enhanced therapeutic potentials.

Authors:  Zhan Yuin Ong; Nikken Wiradharma; Yi Yan Yang
Journal:  Adv Drug Deliv Rev       Date:  2014-11-30       Impact factor: 15.470

6.  Chitosan disrupts the barrier properties of the outer membrane of gram-negative bacteria.

Authors:  I M Helander; E L Nurmiaho-Lassila; R Ahvenainen; J Rhoades; S Roller
Journal:  Int J Food Microbiol       Date:  2001-12-30       Impact factor: 5.277

7.  Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides.

Authors:  Nathaniel P Chongsiriwatana; James A Patch; Ann M Czyzewski; Michelle T Dohm; Andrey Ivankin; David Gidalevitz; Ronald N Zuckermann; Annelise E Barron
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

8.  Chemical structure of cationic groups in amphiphilic polymethacrylates modulates the antimicrobial and hemolytic activities.

Authors:  Edmund F Palermo; Kenichi Kuroda
Journal:  Biomacromolecules       Date:  2009-06-08       Impact factor: 6.988

9.  Antibacterial Low Molecular Weight Cationic Polymers: Dissecting the Contribution of Hydrophobicity, Chain Length and Charge to Activity.

Authors:  James L Grace; Johnny X Huang; Soon-Ee Cheah; Nghia P Truong; Matthew A Cooper; Jian Li; Thomas P Davis; John F Quinn; Tony Velkov; Michael R Whittaker
Journal:  RSC Adv       Date:  2016-01-28       Impact factor: 3.361

10.  Selective antimicrobial activity and mode of action of adepantins, glycine-rich peptide antibiotics based on anuran antimicrobial peptide sequences.

Authors:  Nada Ilić; Mario Novković; Filomena Guida; Daniela Xhindoli; Monica Benincasa; Alessandro Tossi; Davor Juretić
Journal:  Biochim Biophys Acta       Date:  2012-11-27
View more
  3 in total

1.  Silver Nanoparticle Conjugation-Enhanced Antibacterial Efficacy of Clinically Approved Drugs Cephradine and Vildagliptin.

Authors:  Abdulkader Masri; Ayaz Anwar; Dania Ahmed; Ruqaiyyah Bano Siddiqui; Muhammad Raza Shah; Naveed Ahmed Khan
Journal:  Antibiotics (Basel)       Date:  2018-11-15

2.  Photo-Crosslinked Polymeric Matrix with Antimicrobial Functions for Excisional Wound Healing in Mice.

Authors:  Ming-Hsiang Chang; Yu-Ping Hsiao; Chia-Yen Hsu; Ping-Shan Lai
Journal:  Nanomaterials (Basel)       Date:  2018-10-05       Impact factor: 5.076

3.  Making of water soluble curcumin to potentiate conventional antimicrobials by inducing apoptosis-like phenomena among drug-resistant bacteria.

Authors:  Shivangi Yadav; Ashish Kumar Singh; Anand Kumar Agrahari; Kavyanjali Sharma; Anoop Shyam Singh; Munesh Kumar Gupta; Vinod Kumar Tiwari; Pradyot Prakash
Journal:  Sci Rep       Date:  2020-08-26       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.